1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Orticumab : the potential to harness oxidized LDL to reduce coronary inflammation with plaque-targeted therapy
(
- Contribution to journal › Scientific review
- 2021
-
Mark
A Predictive Model of Antibody Binding in the Presence of IgG-Interacting Bacterial Surface Proteins
(
- Contribution to journal › Article